
Advancis Pharmaceutical is now MiddleBrook™ Pharmaceuticals, Inc.
In 2000, MiddleBrook Pharmaceuticals, Inc. made a novel discovery. Bacteria exposed to antibiotics in front-loaded, sequential bursts, or pulses, are killed more efficiently than those exposed to standard antibiotic treatment regimens.
Today, we are working to develop and commercialize pulsatile drug products, applying our patented finding to create a new outlook on anti-infective therapy.
+ Learn more.


